ArticleThorax2009
Mechanisms of adverse effects of {beta}-agonists in asthma.
Article in Thorax, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 41 citations in OpenAlex.
- Adverse Outcomes Associated With Short-Acting Beta-Agonist Overuse in Asthma: A Systematic Review and Meta-Analysis.Allergy · 2025Pooled it
- Perceptions, attitudes, and behaviors of asthma patients towards the use of short-acting β2-agonists: A systematic review.PloS one · 2023Pooled it
- Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.The Cochrane database of systematic reviews · 2015Pooled it
- Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids.The Cochrane database of systematic reviews · 2015Pooled it
- The Wiser Strategy of Using Beta-Agonists in Asthma: Mechanisms and Rationales.Allergy, asthma & immunology research · 2024Review
- Prediction of Asthma Exacerbations in Children.Journal of personalized medicine · 2023Review
- Predictors of excessive short-acting βPostepy dermatologii i alergologii · 2023Article
- Asthma-related hospitalizations after implementing SABA-free asthma management with a maintenance and anti-inflammatory reliever regimen.European clinical respiratory journal · 2022Article
- High Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma.Journal of asthma and allergy · 2021Article
- Short-Acting βAmerican journal of respiratory and critical care medicine · 2020Article
- Nuclear Receptors in Asthma: Empowering Classical Molecules Against a Contemporary Ailment.Frontiers in immunology · 2020Review
- Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation.Frontiers in immunology · 2019Review
- Effect of beta-agonists on LAM progression and treatment.Proceedings of the National Academy of Sciences of the United States of America · 2018Article
- Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype.Pulmonary pharmacology & therapeutics · 2017Article
- Bidirectional Counterregulation of Human Lung Mast Cell and Airway Smooth Muscle β2 Adrenoceptors.Journal of immunology (Baltimore, Md. : 1950) · 2016Article
- Stage-dependent association of BDNF and TGF-β1 with lung function in stable COPD.Respiratory research · 2012Article
- Role of community pharmacists in educating asthmatic patients: A multi-centered cross-sectional study in Ethiopia.Chronic respiratory diseaseArticle
- Immune Modulation in Asthma: Current Concepts and Future Strategies.Respiration; international review of thoracic diseasesReview
Corrections and comments
- Comment on
Authors and funding
2 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.